Traditional US IPO vs De-SPAC: A Cost and Certainty Comparison

The decision for a China-based issuer to list in the United States has historically been a binary one: a traditional initial public offering (IPO) on the New York Stock Exchange (NYSE) or the Nasdaq. The 2020-2022 regulatory crackdown by the Cyberspace Administration of China (CAC) on offshore data security, combined with the passage of the Holding Foreign Companies Accountable Act (HFCAA) in the US, effectively froze the traditional IPO channel for Chinese issuers for a 24-month period. By mid-2023, a new equilibrium had emerged, but the cost structure and execution certainty of the two primary routes — a traditional IPO versus a de-SPAC merger — have diverged materially. Data from SPAC Research and the SEC’s EDGAR database shows that as of Q3 2025, the average de-SPAC transaction for a China-based issuer carries a total cost of USD 8.5 million to USD 12 million, while a traditional US IPO for a comparable company (USD 50 million to USD 200 million raise) costs between USD 4 million and USD 7 million. However, the de-SPAC route offers a critical advantage: execution certainty, with a 92% completion rate for signed deals versus approximately 60% for traditional IPOs that file an F-1 but fail to price within 12 months (source: Dealogic, 2025). This article provides a granular cost and certainty comparison, referencing SEC rules, PCAOB inspection status, and HKEX Listing Rules where relevant, to guide issuers and their advisors.

The Cost Structure: Direct Underwriting vs. Sponsor Economics

The most visible cost differential between a traditional US IPO and a de-SPAC transaction lies in the underwriting fee structure versus the sponsor promote. For a traditional IPO, the standard underwriting commission for a China-based issuer on the Nasdaq or NYSE is 6.0% to 7.0% of the gross proceeds, with a 1.0% to 1.5% management fee and a 5.0% to 5.5% selling concession. For a USD 100 million raise, this translates to USD 6 million to USD 7 million in direct fees. The SEC’s Rule 5110 (FINRA) governs these fee disclosures, and the underwriter’s lock-up period is typically 180 days post-pricing. In contrast, a de-SPAC transaction does not involve a traditional underwriting fee at the merger stage. Instead, the SPAC sponsor receives a promote, which is typically 20.0% of the SPAC’s trust proceeds. For a SPAC with a USD 200 million trust, the promote is valued at USD 40 million in sponsor shares. However, this is not a cash expense for the target company; it is a dilution to the public shareholders. The target company typically pays a financial advisory fee of 2.0% to 3.0% of the transaction value, plus a success fee of 1.0% to 2.0%, to the placement agent or financial advisor. For a USD 200 million de-SPAC, this totals USD 4 million to USD 10 million in cash fees.

A second major cost item is the legal and audit fees. For a traditional US IPO, the total legal and audit cost for a China-based issuer ranges from USD 2.5 million to USD 4.5 million, depending on the complexity of the VIE structure and the number of PRC subsidiaries. This includes fees for US counsel (USD 1.0 million to USD 1.5 million), PRC counsel (USD 500,000 to USD 800,000), and the independent auditor (USD 1.0 million to USD 1.5 million). The PCAOB’s 2023 inspection report on Chinese audit firms (source: PCAOB, 2023) has added a premium of approximately 20% to audit fees for issuers with VIE structures, as the auditor must now provide enhanced documentation on the control arrangements. For a de-SPAC transaction, legal fees are typically higher due to the need to review the SPAC’s charter, the trust agreement, and the merger agreement. Total legal and audit costs for a de-SPAC range from USD 3.5 million to USD 6.0 million. The SEC’s Rule 14a-12 under the Securities Exchange Act of 1934 requires extensive disclosure of the business combination, which drives up legal costs.

A third cost element is the listing fee and ongoing compliance. For a traditional IPO, the NYSE or Nasdaq initial listing fee is USD 150,000 to USD 250,000, with an annual listing fee of USD 50,000 to USD 80,000. For a de-SPAC, the SPAC itself already holds a listing, so the target company assumes the existing listing. However, the target must pay a Nasdaq or NYSE supplemental listing fee of USD 25,000 to USD 50,000 upon consummation of the merger. The ongoing compliance costs are identical for both routes, including SEC filing fees (USD 10,000 to USD 20,000 per year), D&O insurance (USD 500,000 to USD 1.0 million per year), and investor relations (USD 200,000 to USD 500,000 per year).

Execution Certainty: The PIPE vs. The Roadshow

The primary advantage of the de-SPAC route is execution certainty, which is a function of the pre-committed capital in the SPAC trust and the Private Investment in Public Equity (PIPE) that typically accompanies the deal. For a traditional US IPO, the issuer must complete a roadshow, typically 10 to 14 days, during which the underwriter builds the book. The pricing is subject to market conditions at the close of the roadshow. Data from Renaissance Capital (2025) shows that for Chinese issuers filing an F-1 between January 2023 and June 2025, 38% of deals that completed a roadshow failed to price or were postponed indefinitely. This risk is particularly acute for issuers with a market capitalization below USD 300 million, where institutional demand is thin. The SEC’s Rule 430A allows for a price range to be set in the preliminary prospectus, but the final price can be adjusted downward by up to 20% from the mid-point of the range without re-filing. In practice, Chinese issuers have faced price cuts of 15% to 25% in 2024-2025 due to geopolitical risk premiums (source: Bloomberg, 2025).

In a de-SPAC transaction, the target company negotiates a fixed valuation with the SPAC sponsor before the merger agreement is signed. The SPAC trust, which holds the IPO proceeds in a trust account, provides a floor of capital. As of Q3 2025, the average SPAC trust size for a China-focused SPAC is USD 150 million, with a redemption rate of 45% to 65% (source: SPAC Research, 2025). This means that even after redemptions, the target company can expect USD 52.5 million to USD 82.5 million in trust cash. To bridge any shortfall, the target company secures a PIPE, which is a private placement of shares to institutional investors at the same price as the SPAC merger. The PIPE is typically 20% to 40% of the trust size. The key advantage is that the PIPE is committed before the shareholder vote, so the target company knows the exact capital it will receive. The SEC’s Rule 506(b) under Regulation D governs the PIPE, and the investors are typically accredited investors. The completion rate for de-SPAC transactions that have signed a definitive agreement and secured a PIPE is 92% (source: SPAC Research, 2025).

The timing differential is also significant. A traditional US IPO takes 6 to 9 months from the initial confidential filing of the F-1 (under the JOBS Act’s Section 106) to the pricing date. This includes two to three rounds of SEC comments. For a de-SPAC transaction, the timeline is 4 to 6 months from the signing of the merger agreement to the closing. The SEC review of the proxy statement (Schedule 14A) is typically faster than an F-1 review, as the SPAC itself is already a reporting company. The SEC’s Division of Corporation Finance has a dedicated SPAC review team, and the average review period for a de-SPAC proxy statement is 45 to 60 days, compared to 90 to 120 days for an F-1.

The VIE Structure and Regulatory Risk

For China-based issuers, the VIE (Variable Interest Entity) structure remains the dominant vehicle for US listings, despite the 2023 PRC regulations on cross-border data transfers. The VIE structure is used by approximately 95% of Chinese companies listed on the Nasdaq or NYSE (source: SEC, 2024). Both a traditional IPO and a de-SPAC transaction require the same VIE structure. However, the SEC’s 2021 guidance on VIE disclosure (SEC Staff Statement, July 2021) requires extensive disclosure of the contractual arrangements, the PRC legal risks, and the ability of the issuer to enforce the VIE agreements. For a traditional IPO, this disclosure is in the F-1 prospectus. For a de-SPAC, it is in the proxy statement. The cost of drafting this disclosure is identical.

The critical difference lies in the PRC regulatory approval process. Under the 2023 PRC regulations (the “Measures for the Administration of Overseas Securities Offerings and Listings by Domestic Companies”), any Chinese company seeking to list overseas must file a registration with the China Securities Regulatory Commission (CSRC). The CSRC registration process takes 20 to 30 business days for a traditional IPO, but the CSRC has indicated that de-SPAC transactions are subject to a more rigorous review because the target company is effectively “reverse-merging” into a US shell. As of June 2025, the CSRC has approved 12 de-SPAC registrations for Chinese issuers, with an average approval time of 45 business days (source: CSRC, 2025). This adds 2 to 3 months to the de-SPAC timeline compared to a traditional IPO. However, the CSRC has also indicated that it will not approve a de-SPAC transaction if the SPAC sponsor has a history of non-compliance with PRC securities laws.

A second regulatory risk is the data security review by the CAC. Under the 2022 “Measures for the Security Assessment of Data Exports,” any issuer that collects personal information of more than 1 million users must undergo a security assessment. For a traditional IPO, the CAC review is conducted before the F-1 filing. For a de-SPAC, the CAC review is conducted after the merger agreement is signed but before the shareholder vote. In practice, the CAC has taken 60 to 90 days for both routes. The risk of a CAC rejection is the same for both routes, but the cost of a rejection is higher for a de-SPAC because the target company has already incurred the legal fees for the merger agreement and the PIPE.

The Post-Listing Liquidity and Shareholder Base

The liquidity profile of a de-SPAC stock versus a traditional IPO stock differs materially in the first 12 months post-listing. For a traditional IPO, the underwriter typically provides price stabilization through the over-allotment option (greenshoe), which is 15% of the offering size. The underwriter also provides analyst coverage for 40 days post-IPO. The average daily trading volume for a Chinese IPO in the first 6 months is 2.5% to 3.5% of the public float (source: Nasdaq, 2025). For a de-SPAC transaction, there is no greenshoe mechanism. The SPAC sponsor shares are locked up for 6 to 12 months post-merger, but the PIPE investors and the SPAC public shareholders are free to sell immediately. The average daily trading volume for a de-SPAC stock in the first 6 months is 1.0% to 1.5% of the public float (source: SPAC Research, 2025). This lower liquidity is a function of the smaller institutional shareholder base and the absence of a dedicated market maker.

The shareholder base composition is also different. For a traditional IPO, the shareholder base is primarily institutional investors (60% to 70%), with the remainder being retail investors and the issuer’s existing shareholders. For a de-SPAC transaction, the shareholder base is more fragmented. The SPAC public shareholders (who did not redeem) hold 20% to 40%, the PIPE investors hold 15% to 30%, and the SPAC sponsor holds 10% to 20%. The remaining shares are held by the target company’s existing shareholders. This fragmentation can lead to higher stock price volatility, as there is no single anchor shareholder. Data from Bloomberg (2025) shows that the average 30-day volatility for a de-SPAC stock is 55%, compared to 40% for a traditional IPO stock.

A third factor is the ability to raise follow-on capital. For a traditional IPO, the issuer typically has a 6-month lock-up period for existing shareholders. After the lock-up expires, the issuer can conduct a secondary offering or a follow-on offering. For a de-SPAC, the lock-up period for the target company’s shareholders is typically 6 months, but the SPAC sponsor lock-up is 12 months. The issuer can conduct a follow-on offering 90 days post-merger, but the SEC’s Rule 144 restricts the sale of restricted securities. In practice, de-SPAC issuers have found it more difficult to raise follow-on capital because the institutional investor base is less committed. Data from Dealogic (2025) shows that only 15% of de-SPAC issuers completed a follow-on offering within 12 months of the merger, compared to 40% of traditional IPO issuers.

Actionable Takeaways

1. For issuers with a market capitalization below USD 300 million and a need for capital certainty, the de-SPAC route offers a 92% completion rate versus 60% for a traditional IPO, but at a 25% to 40% higher total cost due to legal fees and sponsor dilution.
2. The CSRC registration timeline for a de-SPAC is 45 business days, compared to 20-30 days for a traditional IPO, adding 2-3 months to the overall process and increasing the risk of a regulatory delay.
3. Post-listing liquidity for a de-SPAC stock is 40% to 60% lower than for a traditional IPO in the first 6 months, with average daily trading volume of 1.0% to 1.5% of the public float.
4. The VIE structure disclosure requirements are identical for both routes under SEC guidance, but the CAC data security review timeline is 60-90 days for both, making it the single largest regulatory bottleneck regardless of the listing method.
5. Issuers should negotiate a PIPE commitment of at least 30% of the SPAC trust size to mitigate the risk of redemptions exceeding 60%, and should include a minimum cash condition in the merger agreement to protect against a failed closing.